HOME >> MEDICINE >> NEWS
UCSD's Victor Nizet, M.D., receives Pediatric Infectious Diseases Award

Victor Nizet, M.D., a University of California, San Diego (UCSD) assistant professor of pediatrics and attending physician, Children's Hospital, San Diego, has received the Pediatric Infectious Diseases Young Investigator Award from the national Pediatric Infectious Diseases Society.

Presented to Nizet at the Society's annual meeting last month in Baltimore, the award recognizes young physicians who have made outstanding contributions in clinical or basic research in pediatric infectious diseases.

Nizet Investigates bacteria that produce disease in children, with a particular focus on the pathogens group A and group B streptococcus (strep). Group A strep is the cause of strep throat and invasive infections including necrotizing fasciitis ("flesh-eating disease"), while group B strep is the leading cause of serious bacterial infections in newborn infants. Using molecular genetic methods, Nizet and colleagues discovered different sets of genes in each bacteria that produce potent toxins capable of injuring human cells.

"Our goal was to prove that specific genes were necessary and sufficient for the production of these toxins," Nizet said. "We did this by removing the genes from the strep bacteria and found that the bacteria no longer produced the toxin. The toxin-deficient strains were then found to lack the ability to produce injury or disease in animal models of human strep infection."

The Nizet group also took the genes they had identified and cloned them into other bacteria that normally don't produce toxins. With the new genes added, the benign bacteria became a toxin-producing factory.

As a result of Nizet's findings, researchers now have a better understanding of the two strep bacteria, which he believes will aid in the search for new treatments and disease prevention that specifically target the newly identified toxins.

In addition to these studies, the Nizet group investigates two additional areas anti
'"/>

Contact: Sue Pondrom
spondrom@ucsd.edu
619-543-6163
University of California - San Diego
19-Jun-2002


Page: 1 2

Related medicine news :

1. UCSDs Dr. Leon Thal to receive Potamkin Prize, one of neurosciences highest honors
2. Michelle Trudeau wins 2004 Victor Cohn Prize for Excellence in Medical Reporting
3. Jeffrey S. Flier, M.D., elected to Institute of Medicine
4. William Cohn, M.D., of Beth Israel Deaconess Medical Center, receives the 2000 Distinguished Inventor Award
5. Statement from Claude Lenfant, M.D., NHLBI Director, on Trends in Hypertension
6. UIC professor receives international humanitarian award
7. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
8. Epidemiologist Trichopoulos receives $5.8 million Department of Defense Innovator Award
9. GlaxoSmithKline receives unanimous favorable recommendation by FDA Advisory Committee for Boostrix
10. NYU Child Study Center receives grant from the American Red Cross September 11 recovery program
11. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: UCSD Victor Nizet receives Pediatric Infectious Diseases Award

(Date:8/1/2015)... (PRWEB) , ... August 01, 2015 , ... ... Partners I, L.P. (“GPP”) portfolio company has acquired Premier Physical Therapy & Wellness ... into its portfolio of state-of-the-art clinics. , “Our acquisition of Premier Physical Therapy ...
(Date:8/1/2015)... ... August 01, 2015 , ... Lume Wellness creators Alex, Robert, and Sam have ... the Apple AppStore. , The app is designed to track various metrics of ... tool to view personal health and use this information for positive behavior modification. Lume ...
(Date:8/1/2015)... ... ... “ reTXT ” was featured on NewsWatch as part of its monthly AppWatch, ... iOS, Android, and Windows. Joe Toohey, the host of AppWatch and technology expert, conducted ... any message including ones already sent. , While text messaging has more features than ...
(Date:7/31/2015)... ... 31, 2015 , ... That’s right, the STASH awards have ... The Significant Technological Achievements in Secretive Horticulture (or STASH) Awards, featured in High ... that have stood the test of time. These include lighting products, organic and ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... When the ... stuff, Super-Sod debuted their new type of sod called Leisure Time(TM) zoysia . ... in process. , To commemorate introduction of this new type of sod, Super-Sod is ...
Breaking Medicine News(10 mins):Health News:Professional Physical Therapy Now Largest Outpatient Physical Therapy Provider in Northeast With Acquisition of Premier Physical Therapy & Wellness 2Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2
(Date:7/30/2015)... CHENGDU, China , July 30, 2015 ... "Company"), a pharmaceutical company that specializes in the patented ... active pharmaceutical ingredients (API), provided updates regarding the notice ... MKT LLC (the "Exchange") indicating that the Company was ... set forth in Sections 134 and 1101 of the ...
(Date:7/30/2015)... , July 30, 2015 Eisai Inc. announced ... the United States , European Union and ... and MHLW, respectively) for eribulin, for the treatment of ... received prior chemotherapy for advanced or metastatic disease. ... from a pivotal global Phase 3 clinical trial (Study ...
(Date:7/30/2015)... , July 30, 2015 ... latest report titled, "Continuous Glucose Monitoring Systems Market: Global ... to the report, the global continuous glucose monitoring systems ... and is expected to reach US$ 788.4 Mn by ... period, 2015 to 2020. Global continuous glucose ...
Breaking Medicine Technology:TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4
Cached News: